| 내용 |
[해외채용안내-싱가포르] 생명공학과 관련 글로벌 기업 채용
싱가포르 정부기관인 컨택 싱가포르(Contact Singapore)가 생명공학과 관련 재학생 및 졸업생들 중 싱가포르 내
Abbott, GlaxoSmithKline, Lonza, MSD, Novartis, Pfizer, Roche, Siemens, sanofi-aventis
등
의 글로벌 기업들
해외 취업
에 관심 있는 분들을 위한 취업정보를 아래와 같이 소개해 드리오니 관심있는 학생분들의 많은 지원을 바랍니다.
|
|
 |
|
|
 |
|
|
|
|
| |
| INDUSTRY INSIGHTS |
|
Launch Your Career in the Biomedical Sciences Hub of Asia
Singapore's vision is to be the Biopolis of Asia, a leading international biomedical sciences cluster, where companies can impact global health by achieving excellence and synergies across R&D, manufacturing and headquarter activities.
|
| |
 |
| |
| To sustain a world-class research hub, Singapore continues to focus on attracting and nurturing top scientific talent, and fostering deep and broad collaborative research across the BMS landscape. Singapore aims to double its pipeline of world-class clinician-scientists by 2015 to help grow talent pool and thought leadership in Asian diseases and in areas such as cancer, neurosciences, eye diseases, infectious diseases, and metabolic disorders.
On the clinical research front, US-based bio/pharmaceutical services organisation PAREXEL International is addressing the growing demand for new talent to underpin the rapid expansion of clinical research in Asia by setting up an academic programme in Singapore through an alliance with the National University of Singapore (NUS). The partnership is between PAREXEL Academy, which offers professional training and education courses in clinical research from its base in Berlin, Germany and the NUS Academy of GxP Excellence (NUSAGE).
|
| |
 |
| |
| Today, eight of the world's top pharmaceutical and biotechnology companies have invested in more than 25 commercial-scale manufacturing facilities in Singapore which produce innovative medicines for the global market. They include Abbott, GlaxoSmithKline, Lonza, MSD, Novartis, Pfizer, Roche and sanofi-aventis. In the area of medical technology manufacturing, Singapore has emerged as a leading site in Asia, with more than 25 leading medical technology companies based here.
Recently, MSD, known as Merck in US and Canada, and Singapore's Economic Development Board signed a new agreement under which MSD will expand its presence in Singapore through new manufacturing, marketing, and research investments. Under the agreement, MSD will invest over US$250 million over the next ten years in site improvements at its manufacturing facilities in Tuas, in addition to expanding its biotech operations and adding technology capability to support new product launches. Another S$700 million will be spent beefing up its research capabilities here.
|
| |
 |
Click
here
to find out more about Singapore's Biomedical Sciences industry. |
|
| |
| FAST FACTS |
|
 |
Today, 4,300 researchers carry out biomedical sciences R&D in more than 50 companies, our universities, and 30 public-sector institutes under the Agency for Science, Technology and Research (A*STAR) and the Ministry of Health (MOH). |
|
|
|
The Singapore government has earmarked S$3.7 billion between 2011 and 2015 to enhancing existing biomedical R&D infrastructure, integrating multi-disciplinary research and translating basic science into tangible outcomes. |
|
|
|
Singapore is home to all of top 10 pharmaceutical companies and all of top 10 medical technology companies. |
|
| |
|
|
|
|
|
| |
|
|
| HOT JOBS |
| Contact Singapore warmly welcomes you to embark on a rewarding career in the biomedical sciences sector in Singapore. Click on these featured job titles to know more about each position.
For other career opportunities in Singapore, please visit
www.contactsingapore.sg/jobs
Go to our Contact Singapore website at
www.contactsingapore.sg
for more information on working, investing and living in Singapore.
|
|
|
|
|
|
|
|
|
|
* 자세한 사항은 첨부 및 링크를 참조하세요. 하단 링크에서 바로 해당 기업포지션을 클릭하시면, 온라인지원하기가 가능합니다.
|
